Trials / Recruiting
RecruitingNCT05967741
The Effects of Dietary Erythritol on Platelet Reactivity and Vascular Inflammation
Randomized Controlled Clinical Trial to Gauge the Effects of Dietary Erythritol on Platelet Reactivity and Vascular Inflammation
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- University of California, Davis · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose is to conduct a dietary intervention study in which human participants will consume beverages sweetened with erythritol or aspartame, each for 2 weeks, in a randomized crossover design
Detailed description
There is a strong correlation between plasma erythritol concentrations and adverse cardiovascular events in high risk individuals. It has also been demonstrated that consumption of dietary erythritol leads to high levels of plasma erythritol. There is in vitro evidence that erythritol at comparable concentrations promotes platelet activation. However, there is no direct evidence that links human consumption of erythritol with the onset of platelet activation and adhesion leading to inflammation. The investigators seek to fill this evidence gap by conducting a randomized crossover dietary intervention study in which human participants will consume beverages sweetened with erythritol or aspartame, each for two weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Erythritol | Erythritol is a naturally occurring and non-nutritive sugar alcohol that is classified as generally recognized as safe (GRAS) |
| OTHER | Aspartame | Aspartame consists of two amino acids, phenylalanine and aspartic acid, and a methyl group. It does not have metabolic effects and has served as the blinded control beverage in the investigators' completed NIH-funded clinical trials. |
Timeline
- Start date
- 2023-07-20
- Primary completion
- 2026-05-31
- Completion
- 2026-06-01
- First posted
- 2023-08-01
- Last updated
- 2025-12-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05967741. Inclusion in this directory is not an endorsement.